ヒトメタニューモウイルス診断薬の世界市場レポート 2025年

ヒトメタニューモウイルス診断薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.1％で7億9,000万米ドルに成長します。予測期間中に予想される成長は、早期かつ正確な呼吸器感染症診断への需要の高まり、ポイントオブケア診断ソリューションへの投資の拡大、新興市場におけるヘルスケアアクセスの拡大、パンデミック対策への世界の注力、マルチプレックス呼吸器パネルの統合の拡大などが背景にあります。予測期間における主な動向としては、自動化・高スループット診断システムの開発、分散型診断モデルへのシフト、診断解釈における人工知能の利用、在宅検査キットの採用拡大、公開会社と非公開会社の協力関係の拡大などが挙げられます。

呼吸器感染症の増加は、ヒトメタニューモウイルス診断薬市場の成長を促進すると予想されます。ウイルス、細菌、その他の病原体によって引き起こされる呼吸器感染症は、副鼻腔、咽頭、気道、肺を含む呼吸器系に影響を及ぼします。有病率の増加は、有害な汚染物質への曝露が呼吸器官を刺激し、弱め、感染症にかかりやすくしていることに関連していると考えられます。ヒトメタニューモウイルス診断薬は、呼吸器感染症の原因としてhMPVを特定し、正確な治療とより良い管理を可能にします。例えば、2025年1月、英国健康安全保障局は、2023年から2024年のシーズン中、イングランドにおける呼吸器感染率は、2023年の第50週と第52週に10万人当たり8人とピークに達し、2024年の第4週には10万人当たり10.2人とさらに上昇し、閉鎖環境における急性呼吸器感染症発生件数は2,051件に達し、ほとんどの症例が介護施設と病院で報告されたと報告しました。このように呼吸器感染症の流行が拡大していることが、ヒトメタニューモウイルス診断薬市場の拡大に拍車をかけています。

ヒトメタニューモウイルス診断薬市場の主要企業は、呼吸器ポリメラーゼ連鎖反応（PCR）診断ツールなどの革新的ソリューションの開発に注力し、幅広い呼吸器病原体を検出する分子診断能力を強化しています。呼吸器PCR診断ソリューションは、呼吸器病原体の遺伝物質を高感度・高特異性で増幅して検出・同定するための分子検査法です。例えば、2023年3月、中国に拠点を置く分子診断会社であるJiangsu BioPerfectus Technologies Co, Ltd.は、呼吸器病原体多重リアルタイムPCR診断キットを発売しました。このソリューションは、複数の呼吸器病原体を同時に高精度で迅速に検出するよう設計されており、臨床現場やポイントオブケアでの診断効率を向上させる。その広範なカバレッジと正確な性能は、特に症状が重複する呼吸器感染症の管理において、タイムリーな臨床的意思決定を大幅に支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のヒトメタニューモウイルス診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヒトメタニューモウイルス診断薬市場：成長率分析
• 世界のヒトメタニューモウイルス診断薬市場の実績：規模と成長、2019年～2024年
• 世界のヒトメタニューモウイルス診断薬市場の予測：規模と成長、2024年～2029年、2034年
• 世界のヒトメタニューモウイルス診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒトメタニューモウイルス診断薬市場：製品タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 試薬とキット
• 機器
• 世界のヒトメタニューモウイルス診断薬市場：テストタイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 分子診断
• 免疫診断
• 文化に基づく方法
• その他のテストの種類
• 世界のヒトメタニューモウイルス診断薬市場：技術別、実績と予測、2019年～2024年、2024年～2029年、2034年
• PCRベースの診断
• 次世代シーケンシング（NGS）
• 免疫蛍光アッセイ
• ラテラルフローアッセイ
• マイクロアレイ技術
• その他の先進技術
• 世界のヒトメタニューモウイルス診断薬市場：最終用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院と診療所
• 診断および参照検査室
• 学術研究機関
• その他のエンドユーザー
• 世界のヒトメタニューモウイルス診断薬市場、試薬とキットの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• サンプル採取キット
• 核酸抽出キット
• ウイルス輸送媒体
• コントロール試薬
• 世界のヒトメタニューモウイルス診断薬市場、機器の種類別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• サーマルサイクラー
• 自動分析装置
• 核酸抽出装置
• 蛍光リーダー

第7章 地域別・国別分析

• 世界のヒトメタニューモウイルス診断薬市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のヒトメタニューモウイルス診断薬市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒトメタニューモウイルス診断薬市場：競合情勢
• ヒトメタニューモウイルス診断薬市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• ARUP Laboratories
• Qiagen NV
• Diasorin
• Luminex Corporation
• bioMerieux
• Seegene Inc.
• Cepheid
• R-Biopharm AG
• Certest Biotec
• ZeptoMetrix
• Xi'an Tianlong Science and Technology Co. Ltd
• The Native Antigen Company
• Hangzhou Testsea Biotechnology Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒトメタニューモウイルス診断薬市場2029年：新たな機会を提供する国
• ヒトメタニューモウイルス診断薬市場2029年：新たな機会を提供するセグメント
• ヒトメタニューモウイルス診断薬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Human metapneumovirus (hMPV) diagnostics involve the methods and criteria used to detect and confirm infection with human metapneumovirus, a respiratory pathogen that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in children, the elderly, and immunocompromised individuals.

The primary product types in human metapneumovirus diagnostics are reagents and kits, as well as instruments. Reagents and kits are essential laboratory products that contain chemical substances and tools for performing specific diagnostic tests or experiments. The diagnostic test types include molecular diagnostics, immunodiagnostics, culture-based methods, and others, utilizing technologies such as PCR-based diagnostics, next-generation sequencing (NGS), immunofluorescence assays, lateral flow assays, microarray technology, and others. These tests are used in various settings, including hospitals and clinics, diagnostic and reference laboratories, academic and research institutions, among others.

The human metapneumovirus diagnostics market research report is one of a series of new reports from The Business Research Company that provides human metapneumovirus diagnostics market statistics, including human metapneumovirus diagnostics industry global market size, regional shares, competitors with a human metapneumovirus diagnostics market share, detailed human metapneumovirus diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the human metapneumovirus diagnostics industry. This human metapneumovirus diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human metapneumovirus diagnostics market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to an increase in pediatric hospitalization rates due to respiratory infections, heightened awareness of viral respiratory pathogens, the initial adoption of molecular diagnostic tools, the expansion of public health surveillance programs, and greater funding for pediatric respiratory diseases.

The human metapneumovirus diagnostics market size is expected to see rapid growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by rising demand for early and accurate respiratory infection diagnostics, growing investments in point-of-care diagnostic solutions, expanding healthcare access in emerging markets, a global focus on pandemic preparedness, and greater integration of multiplex respiratory panels. Key trends in the forecast period include the development of automated and high-throughput diagnostic systems, a shift toward decentralized diagnostic models, the use of artificial intelligence in diagnostic interpretation, the increasing adoption of at-home testing kits, and growing collaboration between public and private diagnostic companies.

The increasing prevalence of respiratory infections is expected to drive growth in the human metapneumovirus diagnostics market. Respiratory infections, caused by viruses, bacteria, or other pathogens, affect the respiratory system, including the sinuses, throat, airways, and lungs. The rising prevalence can be linked to the exposure to harmful pollutants that irritate and weaken the respiratory tract, making it more susceptible to infections. Human metapneumovirus diagnostics help identify hMPV as the cause of respiratory infections, allowing for accurate treatment and better management. For example, in January 2025, the UK Health Security Agency reported that during the 2023-2024 season, respiratory infection rates in England peaked at 8.0 per 100,000 in weeks 50 and 52 of 2023, and rose further to 10.2 per 100,000 in week 4 of 2024, while acute respiratory infection incidents in closed settings reached 2,051, with most cases reported in care homes and hospitals. This growing prevalence of respiratory infections is fueling the expansion of the human metapneumovirus diagnostics market.

Leading companies in the human metapneumovirus diagnostics market are focusing on developing innovative solutions, such as respiratory polymerase chain reaction (PCR) diagnostic tools, to enhance molecular diagnostic capabilities for detecting a wide range of respiratory pathogens. A respiratory PCR diagnostic solution is a molecular testing method used to detect and identify respiratory pathogens by amplifying their genetic material with high sensitivity and specificity. For example, in March 2023, Jiangsu BioPerfectus Technologies Co., Ltd., a molecular diagnostic company based in China, launched its respiratory pathogen multiplex real-time PCR diagnostic kit. This solution is designed to simultaneously detect multiple respiratory pathogens with high accuracy and a rapid turnaround time, improving diagnostic efficiency in clinical and point-of-care settings. Its broad coverage and precise performance significantly aid timely clinical decision-making, particularly for managing respiratory infections with overlapping symptoms.

In February 2024, AstraZeneca plc, a pharmaceutical company based in the UK, acquired Icosavax Inc. for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its late-stage pipeline and expand its expertise in vaccines for respiratory conditions with high burdens, specifically advancing Icosavax's lead investigational combination vaccine candidate, IVX-A12, which targets both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax Inc., a biotechnology company based in the US, focuses on developing vaccines, especially combination vaccines targeting respiratory viruses such as RSV and hMPV.

Major players in the human metapneumovirus diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ARUP Laboratories, Qiagen NV, Diasorin, Luminex Corporation, bioMerieux, Seegene Inc., Cepheid, R-Biopharm AG, Certest Biotec, ZeptoMetrix, Xi'an Tianlong Science and Technology Co. Ltd, The Native Antigen Company, Hangzhou Testsea Biotechnology Co. Ltd., and Attogene.

North America was the largest region in the human metapneumovirus diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human metapneumovirus diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human metapneumovirus diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human metapneumovirus diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, clinical laboratory services, point-of-care testing services, home sample collection services, public health surveillance services, and contract research and testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human metapneumovirus diagnostics market also includes sales of sample collection devices, diagnostic data management tools, test validation kits, and safety and waste disposal systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Metapneumovirus Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human metapneumovirus diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human metapneumovirus diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human metapneumovirus diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Reagents And Kits; Instruments
• 2) By Test Type: Molecular Diagnostics; Immunodiagnostics; Culture Based Methods; Other Test Types
• 3) By Technology: PCR-Based Diagnostics; Next-Generation Sequencing (NGS); Immunofluorescence Assays; Lateral Flow Assays; Microarray Technology; Other Advanced Technologies
• 4) By End-Use: Hospitals And Clinics; Diagnostic And Reference Laboratories; Academic And Research Institutions; Other End Users
• Subsegments:
• 1) By Reagents And Kits: Sample Collection Kits; Nucleic Acid Extraction Kits; Viral Transport Media; Control Reagents
• 2) By Instruments: Thermal Cyclers; Automated Analyzers; Nucleic Acid Extractors; Fluorescence Readers
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quest Diagnostics; Hologic Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Metapneumovirus Diagnostics Market Characteristics

3. Human Metapneumovirus Diagnostics Market Trends And Strategies

4. Human Metapneumovirus Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Metapneumovirus Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Human Metapneumovirus Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Human Metapneumovirus Diagnostics Market Growth Rate Analysis
• 5.4. Global Human Metapneumovirus Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Human Metapneumovirus Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Human Metapneumovirus Diagnostics Total Addressable Market (TAM)

6. Human Metapneumovirus Diagnostics Market Segmentation

• 6.1. Global Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Instruments
• 6.2. Global Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunodiagnostics
• Culture Based Methods
• Other Test Types
• 6.3. Global Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR-Based Diagnostics
• Next-Generation Sequencing (NGS)
• Immunofluorescence Assays
• Lateral Flow Assays
• Microarray Technology
• Other Advanced Technologies
• 6.4. Global Human Metapneumovirus Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic And Reference Laboratories
• Academic And Research Institutions
• Other End Users
• 6.5. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection Kits
• Nucleic Acid Extraction Kits
• Viral Transport Media
• Control Reagents
• 6.6. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thermal Cyclers
• Automated Analyzers
• Nucleic Acid Extractors
• Fluorescence Readers

7. Human Metapneumovirus Diagnostics Market Regional And Country Analysis

• 7.1. Global Human Metapneumovirus Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Human Metapneumovirus Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Metapneumovirus Diagnostics Market

• 8.1. Asia-Pacific Human Metapneumovirus Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Metapneumovirus Diagnostics Market

• 9.1. China Human Metapneumovirus Diagnostics Market Overview
• 9.2. China Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Metapneumovirus Diagnostics Market

• 10.1. India Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Metapneumovirus Diagnostics Market

• 11.1. Japan Human Metapneumovirus Diagnostics Market Overview
• 11.2. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Metapneumovirus Diagnostics Market

• 12.1. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Metapneumovirus Diagnostics Market

• 13.1. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Metapneumovirus Diagnostics Market

• 14.1. South Korea Human Metapneumovirus Diagnostics Market Overview
• 14.2. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Metapneumovirus Diagnostics Market

• 15.1. Western Europe Human Metapneumovirus Diagnostics Market Overview
• 15.2. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Metapneumovirus Diagnostics Market

• 16.1. UK Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Metapneumovirus Diagnostics Market

• 17.1. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Metapneumovirus Diagnostics Market

• 18.1. France Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Metapneumovirus Diagnostics Market

• 19.1. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Metapneumovirus Diagnostics Market

• 20.1. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Metapneumovirus Diagnostics Market

• 21.1. Eastern Europe Human Metapneumovirus Diagnostics Market Overview
• 21.2. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Metapneumovirus Diagnostics Market

• 22.1. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Metapneumovirus Diagnostics Market

• 23.1. North America Human Metapneumovirus Diagnostics Market Overview
• 23.2. North America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Metapneumovirus Diagnostics Market

• 24.1. USA Human Metapneumovirus Diagnostics Market Overview
• 24.2. USA Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Metapneumovirus Diagnostics Market

• 25.1. Canada Human Metapneumovirus Diagnostics Market Overview
• 25.2. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Metapneumovirus Diagnostics Market

• 26.1. South America Human Metapneumovirus Diagnostics Market Overview
• 26.2. South America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Metapneumovirus Diagnostics Market

• 27.1. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Metapneumovirus Diagnostics Market

• 28.1. Middle East Human Metapneumovirus Diagnostics Market Overview
• 28.2. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Metapneumovirus Diagnostics Market

• 29.1. Africa Human Metapneumovirus Diagnostics Market Overview
• 29.2. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Metapneumovirus Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Human Metapneumovirus Diagnostics Market Competitive Landscape
• 30.2. Human Metapneumovirus Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Metapneumovirus Diagnostics Market Other Major And Innovative Companies

• 31.1. QuidelOrtho Corporation
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. ARUP Laboratories
• 31.4. Qiagen NV
• 31.5. Diasorin
• 31.6. Luminex Corporation
• 31.7. bioMerieux
• 31.8. Seegene Inc.
• 31.9. Cepheid
• 31.10. R-Biopharm AG
• 31.11. Certest Biotec
• 31.12. ZeptoMetrix
• 31.13. Xi'an Tianlong Science and Technology Co. Ltd
• 31.14. The Native Antigen Company
• 31.15. Hangzhou Testsea Biotechnology Co. Ltd.

32. Global Human Metapneumovirus Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Metapneumovirus Diagnostics Market

34. Recent Developments In The Human Metapneumovirus Diagnostics Market

35. Human Metapneumovirus Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Human Metapneumovirus Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Human Metapneumovirus Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Human Metapneumovirus Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer